Transgenic and mutant animal models to study mechanisms of protection of red cell genetic defects against malaria.
Malaria, caused by members of the genus Plasmodia, is still the most prevalent parasitic disease in the world. In an attempt to understand genetic factors conferring resistance to malaria, mouse models of thalassemia, sickle trait, and ankyrin and spectrin deficiency were studied during infection with species of malaria infectious to rodents. Although growth of P. falciparum is not inhibited in thalassemic erythrocytes in culture, mice carrying a beta-thalassemia mutation were protected from Plasmodium chabaudi adami, supporting epidemiologic findings. Transgenic mice expressing beta s hemoglobin were also significantly protected from two species of rodent malaria. Importantly, a significant role for the spleen in protection in the beta s transgenic mice was found. Finally, mice deficient in spectrin and ankyrin were studied with respect to their ability to support the growth of malaria. It was found that spectrin deficient mice were almost completely refractory to P. chabaudi adami and P. berghei. These models will allow further study of host factors in resistance to malaria.
Shear
H L
HL
Division of Hematology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10467.
D000818:Animals; D017487:Ankyrins / Q000502:physiology; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D006451:Hemoglobin, Sickle / Q000235:genetics; D006801:Humans; D008288:Malaria / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008817:Mice, Mutant Strains; D008822:Mice, Transgenic; D013049:Spectrin / Q000502:physiology; D017086:beta-Thalassemia / Q000235:genetics*
D017487:Ankyrins; D006451:Hemoglobin, Sickle; D013049:Spectrin